Literature DB >> 6319080

DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA.

L F Liu.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6319080     DOI： 10.3109/10409238309102799

Source DB:  PubMed          Journal:  CRC Crit Rev Biochem        ISSN： 0045-6411


× No keyword cloud information.
  52 in total

1.  Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35.

Authors:  B Grigolo; I Mazzetti; R Meliconi; S Bazzi; R Scorza; M Candela; A Gabrielli; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents.

Authors:  J F Barrett; T D Gootz; P R McGuirk; C A Farrell; S A Sokolowski
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.

Authors:  A Udvardy; P Schedl
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection.

Authors:  M L Gu; S L Rhode
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Archaebacterial reverse gyrase cleavage-site specificity is similar to that of eubacterial DNA topoisomerases I.

Authors:  O I Kovalsky; S A Kozyavkin; A I Slesarev
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

Review 6.  In vitro assays used to measure the activity of topoisomerases.

Authors:  J F Barrett; J A Sutcliffe; T D Gootz
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 7.  Biochemical characteristics and physiological significance of major DNA topoisomerases.

Authors:  J A Sutcliffe; T D Gootz; J F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 8.  Topoisomerase inhibitors. A review of their therapeutic potential in cancer.

Authors:  B K Sinha
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  The effects of inhibitors of topoisomerase II and quinacrine on ultraviolet-light-induced DNA incision in normal and xeroderma pigmentosum fibroblasts.

Authors:  H W Thielmann; O Popanda; L Edler
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.